new video loaded: Merck earnings beat estimates, raises full year guidance Merck posted better than expected sales and profit. The company getting a boost from its diabetes drug Januvia, but strong ...
Evan Seigerman, BMO senior biopharma analyst, joins 'Squawk Box' to discuss Merck's decision to buy Verona, the potential impact of sector tariffs and much more. Got a confidential news tip? We want ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results